Literature DB >> 33713820

Xenopus laevis and human type 3 iodothyronine deiodinase enzyme cross-species sensitivity to inhibition by ToxCast chemicals.

Sally A Mayasich1, Joseph J Korte2, Jeffrey S Denny2, Phillip C Hartig3, Jennifer H Olker2, Philip DeGoey2, Joseph O'Flanagan4, Sigmund J Degitz2, Michael W Hornung5.   

Abstract

Deiodinase enzymes are critical for tissue-specific and temporal control of activation or inactivation of thyroid hormones during vertebrate development, including amphibian metamorphosis. We previously screened ToxCast chemicals for inhibitory activity toward human recombinant Type 3 iodothyronine deiodinase enzyme (hDIO3) and subsequently produced Xenopus laevis recombinant dio3 enzyme (Xldio3) with the goals to identify specific chemical inhibitors of Xldio3, to evaluate cross-species sensitivity and explore whether the human assay results are predictive of the amphibian. We identified a subset of 356 chemicals screened against hDIO3 to test against Xldio3, initially at a single concentration (200 μM), and further tested 79 in concentration-response mode. Most chemicals had IC50 values lower for hDIO3 than for Xldio3 and many had steep Hill slopes (a potential indication of non-specific inhibition). However, eight of the most potent chemicals are likely specific inhibitors, with IC50 values of 14 μM or less, Hill slopes near -1 and curves not significantly different between species likely due to conservation of catalytically active amino acids. Controlling for assay conditions, human in vitro screening results can be predictive of activity in the amphibian assay. This study lays the groundwork for future studies using recombinant non-mammalian proteins to test cross-species sensitivity to chemicals. DISCLAIMER: The views expressed in this paper are those of the authors and do not necessarily reflect the views or policies of the U.S. Environmental Protection Agency. Mention of trade names or commercial products does not constitute endorsement or recommendation for use. Published by Elsevier Ltd.

Entities:  

Keywords:  Deiodinase; Endocrine disruption; Screening; Thyroid; Xenopus laevis

Mesh:

Substances:

Year:  2021        PMID: 33713820      PMCID: PMC8167933          DOI: 10.1016/j.tiv.2021.105141

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.685


  48 in total

1.  Optimization of gene delivery methods in Xenopus laevis kidney (A6) and Chinese hamster ovary (CHO) cell lines for heterologous expression of Xenopus inner ear genes.

Authors:  Daniel Ramirez-Gordillo; Casilda Trujillo-Provencio; V Bleu Knight; Elba E Serrano
Journal:  In Vitro Cell Dev Biol Anim       Date:  2011-09-30       Impact factor: 2.416

2.  Assessment of serum biomarkers in rats after exposure to pesticides of different chemical classes.

Authors:  Virginia C Moser; Nicholas Stewart; Danielle L Freeborn; James Crooks; Denise K MacMillan; Joan M Hedge; Charles E Wood; Rebecca L McMahen; Mark J Strynar; David W Herr
Journal:  Toxicol Appl Pharmacol       Date:  2014-12-09       Impact factor: 4.219

3.  Development of a screening approach to detect thyroid disrupting chemicals that inhibit the human sodium iodide symporter (NIS).

Authors:  Daniel R Hallinger; Ashley S Murr; Angela R Buckalew; Steven O Simmons; Tammy E Stoker; Susan C Laws
Journal:  Toxicol In Vitro       Date:  2016-12-12       Impact factor: 3.500

4.  An Aggregation Advisor for Ligand Discovery.

Authors:  John J Irwin; Da Duan; Hayarpi Torosyan; Allison K Doak; Kristin T Ziebart; Teague Sterling; Gurgen Tumanian; Brian K Shoichet
Journal:  J Med Chem       Date:  2015-08-28       Impact factor: 7.446

5.  ToxCast Chemical Landscape: Paving the Road to 21st Century Toxicology.

Authors:  Ann M Richard; Richard S Judson; Keith A Houck; Christopher M Grulke; Patra Volarath; Inthirany Thillainadarajah; Chihae Yang; James Rathman; Matthew T Martin; John F Wambaugh; Thomas B Knudsen; Jayaram Kancherla; Kamel Mansouri; Grace Patlewicz; Antony J Williams; Stephen B Little; Kevin M Crofton; Russell S Thomas
Journal:  Chem Res Toxicol       Date:  2016-07-20       Impact factor: 3.739

6.  Inhibition of iodothyronine deiodinase by phenolphthalein dyes: structure--activity relationship.

Authors:  D Fekkes; G Hennemann; T J Visser
Journal:  FEBS Lett       Date:  1982-01-11       Impact factor: 4.124

7.  Screening the ToxCast Phase 1 Chemical Library for Inhibition of Deiodinase Type 1 Activity.

Authors:  Michael W Hornung; Joseph J Korte; Jennifer H Olker; Jeffrey S Denny; Carsten Knutsen; Phillip C Hartig; Mary C Cardon; Sigmund J Degitz
Journal:  Toxicol Sci       Date:  2018-04-01       Impact factor: 4.849

8.  An Improved Nonradioactive Screening Method Identifies Genistein and Xanthohumol as Potent Inhibitors of Iodothyronine Deiodinases.

Authors:  Kostja Renko; Sonja Schäche; Carolin S Hoefig; Tim Welsink; Christian Schwiebert; Doreen Braun; Niels-Peter Becker; Josef Köhrle; Lutz Schomburg
Journal:  Thyroid       Date:  2015-06-25       Impact factor: 6.568

9.  Altered RNA binding activity underlies abnormal thyroid hormone metabolism linked to a mutation in selenocysteine insertion sequence-binding protein 2.

Authors:  Jodi L Bubenik; Donna M Driscoll
Journal:  J Biol Chem       Date:  2007-09-27       Impact factor: 5.157

10.  SECISearch3 and Seblastian: new tools for prediction of SECIS elements and selenoproteins.

Authors:  Marco Mariotti; Alexei V Lobanov; Roderic Guigo; Vadim N Gladyshev
Journal:  Nucleic Acids Res       Date:  2013-06-19       Impact factor: 16.971

View more
  1 in total

1.  Characterization of the Mechanistic Linkages Between Iodothyronine Deiodinase Inhibition and Impaired Thyroid-Mediated Growth and Development in Xenopus laevis Using Iopanoic Acid.

Authors:  Jonathan T Haselman; Jennifer H Olker; Patricia A Kosian; Joseph J Korte; Jeffrey S Denny; Joseph E Tietge; Michael W Hornung; Sigmund J Degitz
Journal:  Toxicol Sci       Date:  2022-04-26       Impact factor: 4.109

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.